Company Description

CytoTerra is a proprietary cytogenomics platform developed and owned by Phase Genomics. It utilizes Genomic Proximity Mapping (GPM)—a technique based on Hi-C / chromatin conformation capture technology—to measure 3D DNA interactions within cells, allowing for the comprehensive detection of structural chromosomal abnormalities.